Industries
Healthcare
National Analysts Worldwide was one of the first firms in the nation to develop specialized healthcare marketing capabilities some 40 years ago, and we continue to play a leadership role in this sector. Our experience in new product commercialization forecasting, positioning, and pricing spans every therapeutic category, and includes virtually all types of Rx and OTC drugs, biopharmaceuticals, and imaging agents as well as medical devices and instruments. Our approach is distinguished by …
- An exceptional grasp of clinical practice from HCP and patient perspectives
- Sophisticated understanding of drug and biotechnology platforms
- In-depth knowledge of the regulatory environment and reimbursement dynamics
- Decades of experience that give historic and econometric perspective to marketing consultation
- Specialized expertise in patient-driven marketing models
The portfolio of research techniques we use has been continually updated to support an industry confronting a host of new challenges, including rising development costs, shrinking margins, loss of patent protection, tighter oversight, changing MD-patient dynamics and erosion of public trust.
The firm's active participation in the consumer marketing realm lends a rich perspective to our pharmaceutical modeling and consulting activities. That unique, dual perspective has become critically important with the shift in power away from providers toward patients. At the same time, our understanding of clinical medicine, pharmacology, and the drug development process makes us ideal strategic partners for clients seeking guidance in trials design, label optimization, and creative lifecycle management of maturing compounds.
Methodological rigor and fluency in the regulatory environment also make us an ideal choice for survey research in support of REMS assessments. We have been conducting FDA-mandated assessments for several decades and today, we have a track record in REMS research that we believe is unparalleled.
The NAscence Bio-Innovation Group
Bringing together a flexible folio of commercialized support services for companies developing new pharmaceutical products, the NAscence Bio-Innovation Group at National Analysts Worldwide helps clients make effective, timely decisions on behalf of emerging technologies and pipeline compounds by ensuring that they understand what research they need to do, when they need to do it, and what it all means for the product development process. NAscence Bio-Innovation works collaboratively with companies of all types – private and public, emerging Biotech and "Big Pharma" – to help them spawn innovative products that will flourish in a high-stakes environment.
- B2B
- Communications | Technology | Media
- Consumer Products
- Energy
- Financial Services
- Healthcare
- Residential Design | Technology
- Retail
For more information on National Analysts Worldwide, please e-mail us or call (215) 496-6800.